CTOs on the Move

Give Legacy

www.givelegacy.com

 
Legacy is America`s largest at-home fertility clinic for people with sperm, empowering individuals to learn more about their sperm and proactively plan for their future with secure sperm freezing options. Partnering with leading health plans, fertility benefits providers, US military programs, and financing merchants, Legacy is making industry-leading sperm testing and freezing affordable and accessible.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details
Jack Chu
Vice President of Technology Profile

Similar Companies

Cityblock

Cityblock was founded in 2017 as the first tech-driven provider for communities with complex needs. We deliver better care to where it`s needed most, investing upstream in highly personalized, prevention-oriented health and social care to ultimately drive down costs and improve outcomes. Our tech enables scale by bringing together practical information, coordination, and communication for our members and our care teams. We are adamant about building a radically better member experience for people living in lower-income neighborhoods that have never been prioritized.

Mercy Care Plan

At Mercy Healthcare Group we are committed to serving the needs of small businesses. Whether you are self-employed, an independent contractor, or a small employer with up to 50 employees, we can provide health care coverage for you, your employees and

Global Multi Media Pro Care

Global Multi Media Pro Care is a Joplin, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

St. Luke's Hospital and Health Network

St. Luke's Hospital and Health Network is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Bethlehem, PA. To find more information about St. Luke's Hospital and Health Network, please visit www.slhn.org

Symbiomix Therapeutics

Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.